Camlin Fine Sciences Share Price
Small Cap | Chemicals | NSE: CAMLINFINE | BSE: 532834
₹170.95 1.25 (0.74 %)
Last Updated: 10 Mar 2025 09:56 AM
Overview
Open (₹) 169.20
High (₹) 171.95
Low (₹) 168.00
Prev. Close (₹) 169.70
Volume 17,079
VWAP (₹) 141.96
ROCE (%) 0.89
Industry P/E 58.97
TTM P/E -14.90
P/B Ratio 3.50
Market Cap (₹) Cr.3,179.63
Dividend Yield (%)--
EPS (₹) -5.50
ROE-11.39%
Sales Growth (%) -4.07
Profit Growth (%)-363.44
Day Range
171.95171.95
52 Week Range
83.26172.75
Historical Returns
Returns (6M)
64.53 %
Returns (1Y)
57.72 %
Returns (3Y)
24.15 %
Returns (5Y)
200.65 %
Returns (6M)
64.53 %
Returns (1Y)
57.72 %
Returns (3Y)
24.15 %
Returns (5Y)
200.65 %
SWOT Analysis
- Book value per share improving over the last 2 years
- Growth in Net Profit Margin (QoQ)
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- Positive ROC (9) indicates upward momentum.
- Price above the pivot point indicates bullish sentiment.
- Price above EMA and SMA (50) indicates bullish momentum.
Technicals
Technical Rating
RSI 54.58
MFI 54.97
ATR 10.67
Commodity Channel Index 16.38
ROC125 41.65
ROC21 12.16
Williams %R -61.21
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 147.55 | 152.15 | 156.60 | 143.10 | 138.50 | 134.05 | 129.45 |
Week Ago | 158.50 | 161.95 | 166.90 | 153.55 | 150.10 | 145.15 | 141.70 |
Month Ago | 121.46 | 125.18 | 129.21 | 117.43 | 113.71 | 109.68 | 105.96 |
EMA & SMA
170.95
Current Price
Bullish Moving Averages
20
Bearish Moving Averages
0
5 Day 153.26
9 Day 150.21
10 Day 146.67
12 Day 145.38
14 Day 145.70
20 Day 140.22
26 Day 136.62
50 Day 133.15
100 Day 121.03
200 Day 112.08
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
ASHISH SUBHASH DANDEKAR | block | Sell | 05 Apr, 2024 | ₹97.99 | 23,00,000 | BSE |
ANFIMA NV | block | Buy | 05 Apr, 2024 | ₹97.99 | 23,00,000 | BSE |
ASHISH SUBHASH DANDEKAR | bulk | Sell | 05 Apr, 2024 | ₹97.99 | 23,00,000 | BSE |
ANFIMA NV | bulk | Buy | 05 Apr, 2024 | ₹97.99 | 23,00,000 | BSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
11 Dec, 2024 | Anagha S. Dandekar | Acquisition | ₹ | 5,08,000 | BSE |
11 Dec, 2024 | Ashish S.Dandekar | Acquisition | ₹ | 5,08,000 | BSE |
09 Sept, 2024 | Infinity Holdings | Disposal | ₹102.60 | 6,63,586 | BSE |
09 Sept, 2024 | Infinity Direct Holdings | Disposal | ₹102.73 | 13,38,600 | BSE |
10 Apr, 2024 | Anfima NV | Acquisition | ₹97.99 | 23,00,000 | BSE |
08 Apr, 2024 | Ashish S. Dandekar | Disposal | ₹97.99 | 23,00,000 | BSE |
20 Mar, 2024 | Ashish S. Dandekar | Pledge | ₹100.40 | 10,00,000 | BSE |
12 Mar, 2024 | Infinity Direct Holdings | Disposal | ₹59.50 | 48,11,400 | BSE |
07 Mar, 2024 | Ashish S. Dandekar | Acquisition | ₹113.55 | 48,11,400 | BSE |
01 Mar, 2024 | Ashish S. Dandekar | Pledge | ₹117.50 | 90,00,000 | BSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
22 Nov, 2024 | Rights issue of equity shares of Re. 1/- in the ratio of 5:41 @ premium of Rs. 109/-. | 08 Jan, 2025 | 08 Jan, 2025 |
Announcements
Date | Source | Detail |
---|---|---|
25 Feb, 2025 | BSE India | Update on Press Release |
25 Feb, 2025 | NSE India | Camlin Fine Sciences Limited has informed the Exchange regarding ''Updates on Press Release''. |
25 Feb, 2025 | NSE India | Camlin Fine Sciences Limited has informed the Exchange regarding Acquisition |
24 Feb, 2025 | BSE India | Disclosure Pursuant to Clause 5 of Para B of Part A of Schedule III of SEBI LODR Regulations 2015 |
24 Feb, 2025 | NSE India | Camlin Fine Sciences Limited has informed the Exchange about Agreements |
24 Feb, 2025 | BSE India | Acquisition of Vinpai S.A. |
24 Feb, 2025 | NSE India | Camlin Fine Sciences Limited has informed the Exchange about Acquisition |
19 Feb, 2025 | NSE India | Camlin Fine Sciences Limited has informed the Exchange about Investor Presentation |
19 Feb, 2025 | BSE India | Revised - Investor Presentation |
17 Feb, 2025 | NSE India | Camlin Fine Sciences Limited has informed the Exchange about Transcript |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 07 Feb, 2025 | 14 Feb, 2025 |
Others | Inter alia, to consider, discuss and decide various matters in connection with the Rights Issues. | 01 Jan, 2025 | 02 Jan, 2025 |
Rights issue of Equity Shares | Inter alia, to consider : 1. The revision of the quantum of the proposed Rights isue to an amount not exceeding Rs. 225 crores; and 2. Issue of any debt securities of the Company. | 19 Nov, 2024 | 22 Nov, 2024 |
Quarterly Results | -- | 29 Oct, 2024 | 11 Nov, 2024 |
Quarterly Results | -- | 06 Aug, 2024 | 12 Aug, 2024 |
Audited Results | -- | 10 May, 2024 | 20 May, 2024 |
Quarterly Results | -- | 30 Jan, 2024 | 09 Feb, 2024 |
Quarterly Results | -- | 26 Oct, 2023 | 06 Nov, 2023 |
Quarterly Results | -- | 03 Aug, 2023 | 11 Aug, 2023 |
Audited Results | -- | 04 May, 2023 | 22 May, 2023 |
Share Holding Pattern
Owner Name | Jan, 2025 | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 |
---|
About Camlin Fine Sciences
Camlin Fine Sciences is a Public Limited Listed company incorporated on 30/11/1993 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L74100MH1993PLC075361 and registration number is 075361. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company’s Total Operating Revenue is Rs. 773.26 Cr. and Equity Capital is Rs. 16.75 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1993
Managing Director
Mr. Ashish Dandekar
NSE Symbol
CAMLINFINE
Camlin Fine Sciences Management
Name | Designation |
---|---|
Mr. Ashish Dandekar | Chairman & Managing Director |
Mr. Nirmal Momaya | Managing Director |
Mr. Arjun Dukane | Executive Director -Technical |
Mr. Mahabaleshwar Palekar | Independent Director |
Mr. Pradip Kanakia | Independent Director |
Mr. Amol Shah | Independent Director |
Mr. Sutapa Banerjee | Independent Director |
Mr. Joseph Conrad D'souza | Independent Director |
Ms. Anagha Dandekar | Non Exe.Non Ind.Director |
Mr. Harsha Raghavan | Non Exe.Non Ind.Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
PidiliteInds | ₹1,39,939.12 | ₹2,781.00 ₹2,751.20(1.08%) | ₹2,620.150 - ₹3,414.400 |
Guj.Fluoro | ₹40,980.64 | ₹3,790.00 ₹3,730.60(1.59%) | ₹2,480.000 - ₹4,875.000 |
Apar Ind | ₹24,529.18 | ₹6,059.60 ₹6,106.60(-0.77%) | ₹5,467.550 - ₹11,797.350 |
Himadri Chem | ₹21,469.65 | ₹434.85 ₹434.80(0.01%) | ₹272.800 - ₹688.500 |
Aarti Inds | ₹14,729.18 | ₹407.60 ₹406.30(0.32%) | ₹364.300 - ₹769.500 |
FAQs on Camlin Fine Sciences
What is the share price of Camlin Fine Sciences?
The share price of Camlin Fine Sciences on 10 Mar, 2025 is ₹ 170.95.
What is 52W high and 52W low share price of Camlin Fine Sciences?
The highest and lowest 52W share prices of Camlin Fine Sciences are ₹ 172.750 and ₹ 83.260
What is the market cap of Camlin Fine Sciences?
The market capitalization of Camlin Fine Sciences as of 10 Mar, 2025 is ₹ 3,179.63 Crores
What is the P/E ratio of Camlin Fine Sciences?
The current P/E ratio of Camlin Fine Sciences as of 10 Mar, 2025 is 58.97
What is the PB ratio of Camlin Fine Sciences?
The PB ratio of Camlin Fine Sciences as of 10 Mar, 2025 is 3.50
Top Gainers
BENGALT
BenglTea&Fab
₹176.15
₹146.80 (0.20%)
EDVENSWA
KLK Electric
₹50.12
₹41.77 (0.20%)
AVI
AVI Polymers
₹17.28
₹14.40 (0.20%)
HEMORGANIC
DineshAlorga
₹9.67
₹8.06 (0.20%)
Top Losers
BISIL
Bisleri Guj
₹1.28
₹2.73 (-0.53%)
BROACH
Broach Life
₹20.15
₹23.60 (-0.15%)
PRADHIN
BhagwndasMet
₹0.68
₹19.60 (-0.97%)
NAGAFERT
NFCL
₹6.83
₹8.22 (-0.17%)
Market Indices
Sensex
₹74,332.58
₹74,340.09 (0.00%)